Key Clinical Implications First evidence linking GLP-1RA use to lower obesity-associated cancer incidence specifically in obese, nondiabetic patients Potential dual benefit for weight management and cancer risk reduction Racial disparities in treatment response warrant further investigation and may impact prescribing decisions Findings support existing trends toward expanded GLP-1RA use for obesity management beyond diabetes Bottom Line This large retrospective study provides the first evidence that GLP-1 receptor agonists may be associated with reduced cancer risk in obese adults without diabetes
Performance Enhancement & Health, 3(2), 7892.
But they hit their protein target 6 days out of 7
The side effects which can be seen are nausea, vomiting, constipation so for the patients who are already suffering from peptic ulcer with type 2 diabetes, would it be safer to take this or not
In patients with diabetes, hypoglycemia (particularly when tirzepatide is combined with insulin or sulfonylureas) can also contribute to fatigue symptoms
Else you can go for 2% Benzoyl peroxide serum for daily use for the entire face